webinar

MDPI World Kidney Day 2026 (Session 1)

Name: MDPI World Kidney Day 2026 (Session 1)
Start: 2026-03-12
End: 2026-03-12

12 March 2026

12:00 (CET)

Online

Welcome from
the chair

Welcome to the 1^st session of MDP’s World Kidney Day 2026 Webinar.

The theme of World Kidney Day 2026, “Kidney Health for All: Caring for People, Protecting the Planet,” highlights the urgent need to advance prevention, early detection, and equitable access to kidney care, while also addressing the environmental impact of kidney disease and its treatments. Climate-related risks such as air pollution, heat stress, and dehydration are increasingly linked to kidney disease, and the resource-intensive nature of some therapies underscores the importance of more sustainable healthcare practices.

In this webinar, leading experts from research, clinical practice, and public health will share insights and strategies to improve kidney health outcomes across diverse populations. The session aims to foster collaboration, raise awareness, and support actions that protect both people and the planet through more equitable and sustainable kidney care.

Date: 12 March 2026
Time: 12:00 pm CET | 8:00 pm JPT | 7:00 pm CST Asia

Webinar ID: 827 1459 8486
Webinar Secretariat: journal.webinar@mdpi.com

Meet the Event Chair

Ms. Yiyin Lai

Meet Our Speakers

View all speakers

Dr. Kunitoshi Iseki (井関邦敏)

Nakamura Clinic, Japan (名嘉村クリニック, 日本）;
Dr. Kunitoshi Iseki received his medical degree from Kyushu University, Fukuoka, Japan, in 1974. He completed research and clinical fellowship training in nephrology at the University of Southern California from 1982 to 1986 under Professors S.G. Massry and V.M. Campese. Dr. Iseki has held senior academic and clinical positions at Kyushu University Hospital and Ryukyu University Hospital, where he served as Senior Assistant Professor of Medicine and later as Director of the Dialysis Unit from 1995 to 2016. He is President of the Okinawa–Asia Clinical Investigation Synergy (OACIS), a former Executive Committee Member of KDIGO, and an Honorary Member of the Japanese Society of Nephrology and the Japanese Society for Dialysis Therapy.

Dr. Jing Miao

Mayo Clinic, USA;
Jing Miao, MD, PhD, Associate Professor of Medicine, Nephrologist, Consultant. Dr. Miao is a board-certified nephrologist whose clinical and research work centers on the pathogenesis, diagnosis, and treatment of kidney disease, along with the use of artificial intelligence in nephrology. She has authored more than 100 peer-reviewed publications, including first or senior authorship in journals such as Kidney International, JASN, CJASN, Hypertension, Mayo Clinic Proceedings, KI Reports, NDT, and Kidney360. Her contributions have earned multiple awards for Outstanding Research and Excellent Teaching, and her work has been highlighted by ASN In The Loop, the CJASN cover, Kidney News, STAT News, and Renal Interventions for its influence on clinical care and AI innovation. Dr. Miao serves on the editorial boards of BMC Nephrology and Frontiers in Medicine and reviews for journals including Nature Communications, The Lancet Digital Health, Mayo Clinic Proceedings Digital Health, Pregnancy Hypertension, Renal Failure, NDT, CKJ, and American Journal of Nephrology.

Dr. Saisho Yoshifumi

Saisho Diabetes Clinic, Japan.;
Dr. Yoshifumi Saisho received his medical degree in 1998 and his PhD degree in 2009, both from the Keio University School of Medicine in Tokyo. Dr. Saisho completed a three-year postdoctoral fellowship at the Larry L. Hillblom Islet Research Center at the University of California-Los Angeles’s David Geffen School of Medicine (Prof. Peter C. Butler). Dr. Saisho’s area of interest is Diabetology, especially beta cell dysfunction in diabetes. Dr. Saisho is the author or coauthor of more than 100 publications.

Sponsors and Partners

Organizer

Webinar Recording

Prof. Dr. Kunitoshi Iseki: "For patients with chronic kidney disease (CKD)CKD patients, management of lifestyle, such as maintaining a healthy, diverse diet, engaging in physical activity, cessation of tobacco use, and maintaining an adequate body mass index, is essential. These changes should be implemented gradually, in collaboration with healthcare workers or renal dieticians. In addition, maintaining good sleep hygiene is recommended as part of comprehensive lifestyle management."

Dr. Jing Miao:" Early diagnosis of acute interstitial nephritis (AIN) is crucial. Clinicians should maintain a low threshold for suspecting AIN, particularly in patients with unexplained increases in creatinine and a history of medication exposure. Management involves discontinuation of the offending drug, treatment of the underlying cause, and consideration of early steroid therapy, especially in drug-induced AIN."

Dr. Yoshifumi Saisho: "Type 2 diabetes (T2D) is characterized by insulin resistance and insufficient insulin secretion. However, these two factors are not independent but rather affect each other. This mutual effect could be more easily understood if we considered diabetes from the perspective of the pancreatic beta cell. This approach is referred to as the “beta cell-centric” concept of diabetes, and it discusses the paradigm shift from “glucose-lowering” to “beta cell protection” for the optimal management of T2D. Please also watch our YouTube video at Beyond glucose: A beta-cell centric approach to prevent type 2 diabetes."

The webinar was hosted via Zoom and required registration to attend. The full recording can be found below. In order to learn about future webinars, you can sign up to our newsletter by clicking “Subscribe” at the top of the page.

Relevant Special issue

"Gender Medicine in Kidney Diseases"
Special Issue Editors: Prof. Dr. Francesco Locatelli, Dr. Lucia Del Vecchio and Prof. Dr. Francesca Mallamaci

Deadline for manuscript submissions: 31 March 2026